[go: up one dir, main page]

JPS6463376A - Hybridmer - Google Patents

Hybridmer

Info

Publication number
JPS6463376A
JPS6463376A JP63118391A JP11839188A JPS6463376A JP S6463376 A JPS6463376 A JP S6463376A JP 63118391 A JP63118391 A JP 63118391A JP 11839188 A JP11839188 A JP 11839188A JP S6463376 A JPS6463376 A JP S6463376A
Authority
JP
Japan
Prior art keywords
monoclonal antibody
hybrid
hybridmer
caf
immunized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63118391A
Other languages
English (en)
Other versions
JPH0159869B2 (ja
Inventor
Chiyunnshiyuu Kung Patoritsuku
Goorudosutein Gideon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22277970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS6463376(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of JPS6463376A publication Critical patent/JPS6463376A/ja
Publication of JPH0159869B2 publication Critical patent/JPH0159869B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2881—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD71
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Hybrid Cells (AREA)
JP63118391A 1979-12-04 1988-05-17 Hybridmer Granted JPS6463376A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/100,071 US4364934A (en) 1979-12-04 1979-12-04 Monoclonal antibody to a human early thymocyte antigen and methods for preparing same

Publications (2)

Publication Number Publication Date
JPS6463376A true JPS6463376A (en) 1989-03-09
JPH0159869B2 JPH0159869B2 (ja) 1989-12-20

Family

ID=22277970

Family Applications (2)

Application Number Title Priority Date Filing Date
JP17032680A Granted JPS5695122A (en) 1979-12-04 1980-12-04 Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human early thymocyte cell
JP63118391A Granted JPS6463376A (en) 1979-12-04 1988-05-17 Hybridmer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP17032680A Granted JPS5695122A (en) 1979-12-04 1980-12-04 Hybrid cell line* antibody and method for manufacturing monoclonal antibody to human early thymocyte cell

Country Status (20)

Country Link
US (1) US4364934A (ja)
EP (1) EP0030814B1 (ja)
JP (2) JPS5695122A (ja)
AT (1) ATE13693T1 (ja)
AU (1) AU545181B2 (ja)
CA (1) CA1175367A (ja)
DE (2) DE3070745D1 (ja)
DK (1) DK153891C (ja)
ES (1) ES8301636A1 (ja)
FI (1) FI75599C (ja)
HK (1) HK24186A (ja)
IE (1) IE50724B1 (ja)
IL (1) IL61621A (ja)
MY (1) MY8600518A (ja)
NO (1) NO159887C (ja)
NZ (1) NZ195648A (ja)
PH (1) PH17490A (ja)
PT (1) PT72145B (ja)
YU (1) YU45077B (ja)
ZA (1) ZA807562B (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4691010A (en) * 1979-12-04 1987-09-01 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigen, antibody, and methods
US4624925A (en) * 1979-12-04 1986-11-25 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigens, antibody, and methods
US4434156A (en) 1981-10-26 1984-02-28 The Salk Institute For Biological Studies Monoclonal antibodies specific for the human transferrin receptor glycoprotein
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
JPS60231699A (ja) * 1983-11-09 1985-11-18 Aichiken 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体
FR2560212B1 (fr) * 1984-02-24 1989-12-29 Unicet Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US4562003A (en) * 1984-10-26 1985-12-31 California Biotechnology, Inc. Monoclonal antibodies against alveolar surfactant protein
US5431897A (en) * 1985-04-19 1995-07-11 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
US5100777A (en) * 1987-04-27 1992-03-31 Tanox Biosystems, Inc. Antibody matrix device and method for evaluating immune status
US5085985A (en) * 1987-11-12 1992-02-04 Becton Dickinson & Co. Monoclonal antibodies and their use in a method for monitoring subsets of activated T cells
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
US5252711A (en) * 1989-06-01 1993-10-12 The Gillette Company Monoclonal antibodies useful in deodorizing skin and antibody fragments thereof
SE503225C2 (sv) * 1991-10-30 1996-04-22 Leif Lindholm Konsult Ab Virus-antikroppskomplex för införing av virus i mammalieceller
BR9610050A (pt) 1995-08-16 1999-10-13 Zeneca Ltd Conjugado,sitemas de dois componentes combinados destinados a uso em um hospedeiro, compostos ou um sal destes famaceuticamente aceitavel,enzima,sequencia de polinucleotìdeos e de02 nucleotìdeos,vetor, célula hospedeira,processos de producão de uma enzima e de um conjugado e de tratamento de célulasneoplásticas em um hospedeiro,composicão farmaceutica e plasmìdeo
EP1034003A4 (en) 1997-11-24 2004-07-14 Johnson T Wong METHODS FOR TREATING HIV OR OTHER INFECTIONS USING A T CELL ACTIVATOR OR A VIRAL ACTIVATOR AND ANTIRETROVIRAL COMBINATION THERAPY
US7653260B2 (en) 2004-06-17 2010-01-26 Carl Zeis MicroImaging GmbH System and method of registering field of view
US8582924B2 (en) 2004-06-30 2013-11-12 Carl Zeiss Microimaging Gmbh Data structure of an image storage and retrieval system
TWI726879B (zh) 2015-05-04 2021-05-11 美商Ｃｙｔｏｍｘ生物製藥公司 抗ｃｄ７１抗體類、可活化之抗ｃｄ７１抗體類及使用彼等之方法
WO2025024334A1 (en) 2023-07-21 2025-01-30 Marrow Therapeutics, Inc. Hematopoietic cell targeting conjugates and related methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
US4284412A (en) * 1979-07-13 1981-08-18 Ortho Diagnostics, Inc. Method and apparatus for automated identification and enumeration of specified blood cell subclasses

Also Published As

Publication number Publication date
DE3070745D1 (en) 1985-07-11
ES497424A0 (es) 1983-01-01
CA1175367A (en) 1984-10-02
AU6496180A (en) 1981-06-11
IE50724B1 (en) 1986-06-25
JPH0159869B2 (ja) 1989-12-20
AU545181B2 (en) 1985-07-04
FI803756L (fi) 1981-06-05
DE30814T1 (de) 1984-07-19
NZ195648A (en) 1984-07-06
PT72145B (en) 1982-07-05
IL61621A (en) 1984-07-31
HK24186A (en) 1986-04-11
DK153891C (da) 1989-02-20
DK153891B (da) 1988-09-19
IE802510L (en) 1981-06-04
NO159887C (no) 1989-02-15
NO803660L (no) 1981-06-05
FI75599B (fi) 1988-03-31
EP0030814A3 (en) 1981-12-30
PT72145A (en) 1981-01-01
US4364934A (en) 1982-12-21
MY8600518A (en) 1986-12-31
YU306480A (en) 1984-04-30
EP0030814A2 (en) 1981-06-24
ZA807562B (en) 1982-07-28
FI75599C (fi) 1988-07-11
DK517280A (da) 1981-06-05
PH17490A (en) 1984-09-04
JPS5695122A (en) 1981-08-01
ES8301636A1 (es) 1983-01-01
EP0030814B1 (en) 1985-06-05
ATE13693T1 (de) 1985-06-15
NO159887B (no) 1988-11-07
YU45077B (en) 1992-03-10
JPS6363557B2 (ja) 1988-12-07

Similar Documents

Publication Publication Date Title
GR72923B (ja)
GR67298B (ja)
GR72758B (ja)
IL59622A0 (en) Monoclonal antibody to human t cells and its production
GR72922B (ja)
JPS6463376A (en) Hybridmer
IE802508L (en) Monoclonal antibody to thymocytes